Skandinaviska Enskilda Banken AB publ Buys 6,400 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Skandinaviska Enskilda Banken AB publ increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 89,251 shares of the company’s stock after acquiring an additional 6,400 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in GE HealthCare Technologies were worth $6,954,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Wynn Capital LLC increased its position in GE HealthCare Technologies by 4.1% during the first quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock worth $284,000 after acquiring an additional 122 shares during the period. Fiduciary Trust Co increased its position in GE HealthCare Technologies by 1.8% during the fourth quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock worth $595,000 after acquiring an additional 133 shares during the period. Quent Capital LLC increased its position in GE HealthCare Technologies by 21.3% during the first quarter. Quent Capital LLC now owns 780 shares of the company’s stock worth $71,000 after acquiring an additional 137 shares during the period. Tempus Wealth Planning LLC boosted its stake in GE HealthCare Technologies by 0.5% during the second quarter. Tempus Wealth Planning LLC now owns 30,892 shares of the company’s stock worth $2,407,000 after buying an additional 141 shares in the last quarter. Finally, Little House Capital LLC boosted its stake in GE HealthCare Technologies by 1.8% during the second quarter. Little House Capital LLC now owns 8,074 shares of the company’s stock worth $629,000 after buying an additional 141 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on GEHC shares. The Goldman Sachs Group started coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They set a “neutral” rating and a $87.00 price target on the stock. Stifel Nicolaus started coverage on shares of GE HealthCare Technologies in a research note on Tuesday, August 6th. They set a “buy” rating and a $100.00 price target on the stock. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research note on Wednesday. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 price target on the stock. Finally, Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Six equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $95.00.

Insider Buying and Selling

In related news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now owns 17,509 shares in the company, valued at approximately $1,414,377.02. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.27% of the stock is owned by corporate insiders.

GE HealthCare Technologies Stock Down 0.4 %

Shares of NASDAQ GEHC opened at $90.28 on Friday. The firm’s 50-day simple moving average is $84.06 and its 200 day simple moving average is $83.34. The company has a market cap of $41.21 billion, a price-to-earnings ratio of 26.40, a price-to-earnings-growth ratio of 3.26 and a beta of 1.17. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.02. The business had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The firm’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.92 EPS. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.